These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 1721388

  • 1. Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506.
    Hossein-Nia M, Devlin JJ, Fagbohun M, Tredger JM, Williams R, Johnston A, Holt DW.
    Transplant Proc; 1991 Dec; 23(6):3150-2. PubMed ID: 1721388
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient.
    Takamatsu Y, Ishizu M, Ichinose I, Ogata K, Onoue M, Kumagawa M, Suzumiya J, Tamura K.
    Bone Marrow Transplant; 2001 Aug; 28(4):421-3. PubMed ID: 11571519
    [Abstract] [Full Text] [Related]

  • 3. Conversion from cyclosporine to tacrolimus after pancreas transplantation.
    Hariharan S, Munda R, Demmy AM, Schroeder TJ, Alexander JW, First MR.
    Transplant Proc; 1995 Dec; 27(6):2981-2. PubMed ID: 8539799
    [No Abstract] [Full Text] [Related]

  • 4. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
    Ji SM, Li LS, Sha GZ, Chen JS, Liu ZH.
    Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
    Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P.
    Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H.
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract] [Full Text] [Related]

  • 12. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506.
    Lopez OL, Martinez AJ, Torre-Cisneros J.
    Transplant Proc; 1991 Dec; 23(6):3181-2. PubMed ID: 1721400
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group.
    Bäckman L, Levy MF, Klintmalm G.
    Transplant Proc; 1995 Feb; 27(1):1124. PubMed ID: 7533361
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.